Rocket PharmaceuticalsRCKT

那斯達克 · USD
3.72
+0.08
(+2.20%)
盤中 01/22 01:31 (UTC+8)
01/22 01:31 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
52,24771,149-62,694-73,71267,37563,27965,42968,757
研發費用
34,06842,65835,94237,35742,31546,34545,22741,74446,84451,383
推銷及管理費用
18,35125,02028,44625,33727,10927,36722,14821,53518,58517,374
非經常性項目費用
-1723,471--------
其他營業費用
----------
營業利益
-52,247
-71,149
-64,388
-62,694
-69,424
-73,712
-67,375
-63,279
-65,429
-68,757
其他收入及費用
2,3882,7033,5262,8403,1764,5375,7924,0893,9993,524
利息費用
473473472473471471471470469468
稅前純益
-50,332
-68,919
-61,334
-60,327
-66,719
-69,646
-62,054
-59,660
-61,899
-65,701
所得稅
----------
稅後純益
-50,332
-68,919
-61,334
-60,327
-66,719
-69,646
-62,054
-59,660
-61,899
-65,701
基本每股稅後盈餘(元)
-0.45-0.62-0.56-0.62-0.71-0.74-0.66-0.64-0.75-0.82
稀釋每股稅後盈餘(元)
-0.45-0.62-0.56-0.62-0.71-0.74-0.66-0.62-0.75-0.82
基本平均股數(千股)
111571.00111019.00110093.0097530.0094158.0093746.0093549.0093336.0082636.0080472.00
稀釋平均股數(千股)
111571.00111019.00110093.0097530.0094158.0093746.0093549.0093336.0082636.0080472.00
還原基本每股稅後盈餘(元)
-0.45-0.62-0.56-0.62-0.71-0.74-0.66-0.64-0.75-0.82
還原稀釋每股稅後盈餘(元)
-0.45-0.62-0.56-0.62-0.71-0.74-0.66-0.62-0.75-0.82
還原基本平均股數(千股)
111,571111,019110,09397,53094,15893,74693,54993,33682,63680,472
還原稀釋平均股數(千股)
111,571111,019110,09397,53094,15893,74693,54993,33682,63680,472
EBITDA(千元)
-48,218-68,079-59,948-58,716-65,708-69,046-62,083-60,347-61,916-65,990

大家都在看

HOT